Department of Periodontics and Oral Implantology, Post Graduate Institute of Dental Sciences, Rohtak, Haryana, India.
Department of Obstetrics and Gynecology, Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.
J Periodontol. 2017 Oct;88(10):999-1011. doi: 10.1902/jop.2017.170121. Epub 2017 Jun 9.
The purpose of this study is to evaluate the effect of non-surgical periodontal therapy and medical treatment on the level of a serologic marker of inflammation (high-sensitivity C-reactive protein [hsCRP]) and insulin resistance (homeostatic model assessment [HOMA]) in women with polycystic ovary syndrome (PCOS) and chronic periodontitis (CP).
Women with PCOS and CP (n = 60) were randomly divided into two groups. The test group was treated with scaling and root planing (SRP) and myo-inositol (MI). The control group was treated with MI and given oral hygiene instructions. Anthropometric, metabolic, and periodontal parameters were assessed at baseline and re-evaluated at 3 and 6 months. All parameters of both groups at 6 months were compared with 25 systemically and periodontally healthy females (group A).
Periodontal parameters were significantly improved in the test group compared with the control group at 3- and 6-month follow-up (P <0.001). A statistically significant reduction was observed in hsCRP and HOMA in both groups at 3- and 6-month follow-up (P <0.05). However, significantly more improvement in hsCRP (P <0.05) and a statistically comparable reduction in HOMA (P >0.05) was observed in the test group compared with the control group at 3 and 6 months. Both the test and control group showed significant consistent improvement in metabolic parameters at 3- and 6-month follow-up, which was further comparable to group A.
SRP together with medical treatment results in a greater reduction of systemic inflammatory burden compared with medical treatment alone in management of women with PCOS and CP.
本研究旨在评估非手术牙周治疗和药物治疗对多囊卵巢综合征(PCOS)和慢性牙周炎(CP)女性血清炎症标志物(高敏 C 反应蛋白 [hsCRP])和胰岛素抵抗(稳态模型评估 [HOMA])水平的影响。
将 60 名患有 PCOS 和 CP 的女性随机分为两组。实验组接受牙周洁治和根面平整(SRP)联合肌醇(MI)治疗,对照组接受 MI 治疗和口腔卫生指导。在基线时和 3 个月、6 个月时评估所有女性的人体测量、代谢和牙周参数。将两组 6 个月时的所有参数与 25 名系统和牙周健康的女性(A 组)进行比较。
与对照组相比,实验组在 3 个月和 6 个月的随访中牙周参数明显改善(P <0.001)。两组在 3 个月和 6 个月的随访中 hsCRP 和 HOMA 均显著降低(P <0.05)。然而,实验组在 3 个月和 6 个月时的 hsCRP 改善更明显(P <0.05),HOMA 降低虽无统计学差异(P >0.05),但与对照组相比仍具有可比性。两组在 3 个月和 6 个月的随访中代谢参数均有显著持续改善,与 A 组相比也具有可比性。
与单纯药物治疗相比,SRP 联合药物治疗可显著降低 PCOS 和 CP 女性的全身炎症负担。